共 50 条
- [42] Incidence of Appropriate Cardioverter-Defibrillator Shocks and Mortality in Patients With Heart Failure Treated With Combined Cardiac Resynchronization Plus Implantable Cardioverter-Defibrillator Therapy Versus Implantable Cardioverter-Defibrillator Therapy JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2010, 15 (01) : 37 - 40
- [44] Association between implantable cardioverter-defibrillator therapy and different lead positions in patients with cardiac resynchronization therapy EUROPACE, 2018, 20 (09): : E133 - E139
- [46] The MADIT-ICD benefit score helps to select implantable cardioverter-defibrillator candidates in cardiac resynchronization therapy EUROPACE, 2022, 24 (08): : 1276 - 1283
- [47] Cardiac resynchronization implantable cardioverter defibrillator: normal or abnormal behaviour? EUROPACE, 2010, 12 (01): : 139 - 141
- [48] Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter defibrillator therapy EUROPACE, 2018, 20 (08): : 1303 - 1311
- [50] Long-term quality of life and uncertainty in patients living with an implantable cardioverter defibrillator HEART & LUNG, 2005, 34 (06): : 386 - 392